The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Predicting bortezomib-related severe neurologic adverse events by measuring proteasome activity in PBMCs.
Yukiko Cho
No relevant relationships to disclose
Mitsuo Hori
No relevant relationships to disclose
Yasushi Okoshi
No relevant relationships to disclose
Takuya Komeno
No relevant relationships to disclose
Chikashi Yoshida
No relevant relationships to disclose
Yukitaka Katsura
No relevant relationships to disclose
Ikuyo Ota
No relevant relationships to disclose
Atsushi Shinagawa
No relevant relationships to disclose
Daisuke Kudo
No relevant relationships to disclose
Seiichi Shimizu
No relevant relationships to disclose
Katsuhiro Sasaki
No relevant relationships to disclose
Keiji Tanaka
No relevant relationships to disclose
Harumi Mukai
No relevant relationships to disclose
Hiroshi Kojima
No relevant relationships to disclose